Schonfeld Strategic Advisors’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
Schonfeld Strategic Advisors's RXST Position: Q2 2026 in Review
Schonfeld Strategic Advisors increased its RxSight (RXST) stake by 266% in Q2 2026, buying an estimated $3.08M and bringing the position to 701,417 shares worth $3.38M. The position accounts for 0.01% of the portfolio, ranked #803.
Schonfeld Strategic Advisors first reported a position in RXST in Q4 2022 and has held it in 14 quarters since. The position peaked at $8.46M in Q1 2024. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.
- Schonfeld Strategic Advisors held 701,417 shares of RxSight worth $3.38M as of Q2 2026.
- Schonfeld Strategic Advisors bought 509,717 RxSight shares in Q2 2026, an estimated $3.08M.
- RxSight made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #803 holding.
- Schonfeld Strategic Advisors first reported a position in RxSight in Q4 2022 and has held it in 14 quarters since.
- Schonfeld Strategic Advisors's RxSight position peaked at $8.46M in Q1 2024.
- 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.